Effects of (−)‐MBP, a novel 5‐HT(2C) agonist and 5‐HT(2A/2B) antagonist/inverse agonist on brain activity: A phMRI study on awake mice

A novel serotonin ligand (−)‐MBP was developed for the treatment of schizophrenia that has 5‐HT(2A/2B) antagonist activity together with 5‐HT(2C) agonist activity. The multi‐functional activity of this novel drug candidate was characterized using pharmacological magnetic resonance imaging. It was hy...

Descripción completa

Detalles Bibliográficos
Autores principales: Sathe, Preeti K., Ramdasi, Gargi R., Giammatteo, Kaylie, Beauzile, Harvens, Wang, Shuyue, Zhang, Heng, Kulkarni, Praveen, Booth, Raymond G., Ferris, Craig F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576165/
https://www.ncbi.nlm.nih.gov/pubmed/37837184
http://dx.doi.org/10.1002/prp2.1144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576165/
https://www.ncbi.nlm.nih.gov/pubmed/37837184
http://dx.doi.org/10.1002/prp2.1144

Ejemplares similares